Terkko Navigator / Leukemia

Hematological manifestations of Good syndrome

Single base substitution mutational signatures in pediatric acute myeloid leukemia based on whole genome sequencing

Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer

Correction to: FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial AALL0631

A typical acute lymphoblastic leukemia JAK2 variant, R683G, causes an aggressive form of familial thrombocytosis when germline

Emil J Freireich and Baruch Spinoza: birds of a feather?

Emil J. Freireich: Legend in Cancer Research (March 16, 1927 to February 1, 2021)

Activity of venetoclax-based therapy in chronic myelomonocytic leukemia

External validation of the FIRST trial’s simplified frailty score in a population-based cohort

Can we prevent childhood Leukaemia?

Prevention of childhood leukaemia by lifestyle changes

Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia

Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated origin

Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape

Temporal multiomic modeling reveals a B-cell receptor proliferative program in chronic lymphocytic leukemia

Unmanipulated haploidentical hematopoietic stem cell transplantation is an excellent option for children and young adult relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after CAR-T-cell therapy

RNA-sequencing data-driven dissection of human plasma cell differentiation reveals new potential transcription regulators

Hematopoietic stem progenitor cells lacking HLA differ from those lacking GPI-anchored proteins in the hierarchical stage and sensitivity to immune attack in patients with acquired aplastic anemia

Significance of chromosome 2p gain in ibrutinib-treated chronic lymphocytic leukemia patients

GSK-3: a multifaceted player in acute leukemias

Phenotypic characterization of leukemia-initiating stem cells in chronic myelomonocytic leukemia

Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from

Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era

Sensitivity and reliability of DNA-based mutation analysis by allele-specific digital PCR to follow resistant BCR-ABL1-positive cells

Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant

RNA methylation in hematological malignancies and its interactions with other epigenetic modifications

Measurable residual disease as a biomarker in acute myeloid leukemia: theoretical and practical considerations

CCR5 maintains macrophages in the bone marrow and drives hematopoietic failure in a mouse model of severe aplastic anemia

Ruxolitinib withdrawal due to the COVID-19

Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial

The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma

EOMES is essential for antitumor activity of CD8+ T cells in chronic lymphocytic leukemia

Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells

Correction: complex landscape of alternative splicing in myeloid neoplasms

Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia

Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networks

Chronic myelomonocytic leukemia diagnosis and management

CAR T cells targeting CD13 controllably induce eradication of acute myeloid leukemia with a single domain antibody switch

Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial

Folate metabolism: a re-emerging therapeutic target in haematological cancers

Edward Shelton Henderson MD Chemotherapy Pioneer July 19, 1932 to June 24, 2020

Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies

Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma

Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia

A prognostic survival model based on metabolism-related gene expression in plasma cell myeloma

Molecular biology of Hodgkin lymphoma

Targeted based therapy in nodal T-cell lymphomas

Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia

Predictive factors for the development of leukemia in patients with transient abnormal myelopoiesis and Down syndrome

Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms